LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.0016667
24.81 84.90 1720 1769 0.9720 0.9871
MN20160318_Q02
L04
MCF 10A-H2B-mCherry Trametinib
0.0016667
26.51 84.90 24 1923 0.0125 -0.2447
MN20160318_Q02
K14
MCF 10A-H2B-mCherry Trametinib
0.0016667
26.51 84.90 1774 1923 0.9224 0.9645
MN20160318_Q02
K14
MCF 10A-H2B-mCherry Trametinib
0.0016667
26.51 84.90 1750 1923 0.9100 0.9585
MN20160318_Q02
L04
MCF 10A-H2B-mCherry Trametinib
0.0016667
26.51 84.90 1790 1923 0.9308 0.9684
MN20160318_Q02
L04
MCF 10A-H2B-mCherry Trametinib
0.0016667
28.21 84.90 32 2091 0.0153 -0.1903
MN20160318_Q02
K14
MCF 10A-H2B-mCherry Trametinib
0.0016667
28.21 84.90 1912 2091 0.9142 0.9616
MN20160318_Q02
K14
MCF 10A-H2B-mCherry Trametinib
0.0016667
28.21 84.90 1783 2091 0.8525 0.9321
MN20160318_Q02
L04
MCF 10A-H2B-mCherry Trametinib
0.0016667
28.21 84.90 1815 2091 0.8678 0.9396
MN20160318_Q02
L04
MCF 10A-H2B-mCherry Trametinib
0.0016667
29.92 84.90 53 2237 0.0237 -0.0950
MN20160318_Q02
K14
MCF 10A-H2B-mCherry Trametinib
0.0016667
29.92 84.90 2027 2237 0.9058 0.9585
MN20160318_Q02
K14
MCF 10A-H2B-mCherry Trametinib
0.0016667
29.92 84.90 1902 2237 0.8500 0.9323
MN20160318_Q02
L04
MCF 10A-H2B-mCherry Trametinib
0.0016667
29.92 84.90 1928 2237 0.8616 0.9379
MN20160318_Q02
L04
MCF 10A-H2B-mCherry Trametinib
0.0016667
31.62 84.90 74 2449 0.0302 -0.0279
MN20160318_Q02
K14
MCF 10A-H2B-mCherry Trametinib
0.0016667
31.62 84.90 2130 2449 0.8695 0.9432
MN20160318_Q02
K14
MCF 10A-H2B-mCherry Trametinib
0.0016667
31.62 84.90 2022 2449 0.8254 0.9224
MN20160318_Q02
L04
MCF 10A-H2B-mCherry Trametinib
0.0016667
31.62 84.90 2044 2449 0.8344 0.9267
MN20160318_Q02
L04
MCF 10A-H2B-mCherry Trametinib
0.0016667
33.32 84.90 89 2722 0.0327 0.0095
MN20160318_Q02
K14
MCF 10A-H2B-mCherry Trametinib
0.0016667
33.32 84.90 2266 2722 0.8324 0.9280
MN20160318_Q02
K14
MCF 10A-H2B-mCherry Trametinib
0.0016667
33.32 84.90 2128 2722 0.7817 0.9039
MN20160318_Q02
L04
MCF 10A-H2B-mCherry Trametinib
0.0016667
33.32 84.90 2145 2722 0.7879 0.9069
MN20160318_Q02
L04
MCF 10A-H2B-mCherry Trametinib
0.0016667
35.03 84.90 129 2991 0.0431 0.0848
MN20160318_Q02
K14
MCF 10A-H2B-mCherry Trametinib
0.0016667
35.03 84.90 2386 2991 0.7976 0.9139
MN20160318_Q02
K14
MCF 10A-H2B-mCherry Trametinib
0.0016667
35.03 84.90 2164 2991 0.7234 0.8779
MN20160318_Q02
L04
MCF 10A-H2B-mCherry Trametinib
0.0016667
35.03 84.90 2179 2991 0.7284 0.8804
MN20160318_Q02
L04